Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1983 Jan;23(1):169–171. doi: 10.1128/aac.23.1.169

Toxicity of amphotericin B, miconazole, and ketoconazole to human granulocyte progenitor cells in vitro.

T C Meeker, M S Siegel, F M Shiota, J J Crowley, R W McGuffin
PMCID: PMC184637  PMID: 6299181

Abstract

Granulocyte progenitor cells were grown in culture with amphotericin B, miconazole, and ketoconazole. Significant suppression of progenitor cell growth could be demonstrated with all three drugs at increasing concentrations. No additive suppression was seen when amphotericin B and ketoconazole were combined.

Full text

PDF
169

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. E. Chemotherapy of systemic mycoses (first of two parts). N Engl J Med. 1974 Jan 3;290(1):30–32. doi: 10.1056/NEJM197401032900107. [DOI] [PubMed] [Google Scholar]
  2. Bindschadler D. D., Bennett J. E. A pharmacologic guide to the clinical use of amphotericin B. J Infect Dis. 1969 Oct;120(4):427–436. doi: 10.1093/infdis/120.4.427. [DOI] [PubMed] [Google Scholar]
  3. Brass C., Galgiani J. N., Blaschke T. F., Defelice R., O'Reilly R. A., Stevens D. A. Disposition of ketoconazole, an oral antifungal, in humans. Antimicrob Agents Chemother. 1982 Jan;21(1):151–158. doi: 10.1128/aac.21.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Catanzaro A., Einstein H., Levine B., Ross J. B., Schillaci R., Fierer J., Friedman P. J. Ketoconazole for treatment of disseminated coccidioidomycosis. Ann Intern Med. 1982 Apr;96(4):436–440. doi: 10.7326/0003-4819-96-4-436. [DOI] [PubMed] [Google Scholar]
  5. Chan C. S., Tuazon C. U., Lessin L. S. Amphotericin-B-induced thrombocytopenia. Ann Intern Med. 1982 Mar;96(3):332–333. doi: 10.7326/0003-4819-96-3-332. [DOI] [PubMed] [Google Scholar]
  6. Graybill J. R., Drutz D. J., Murphy A. L. Ketoconazole: a major innovation for treatment of fungal disease. Ann Intern Med. 1980 Dec;93(6):921–923. doi: 10.7326/0003-4819-93-6-921. [DOI] [PubMed] [Google Scholar]
  7. Graybill J. R., Williams D. M., Van Cutsem E., Drutz D. J. Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole. Rev Infect Dis. 1980 Jul-Aug;2(4):551–558. doi: 10.1093/clinids/2.4.551. [DOI] [PubMed] [Google Scholar]
  8. Hann I. M., Prentice H. G., Corringham R., Blacklock H. A., Keaney M., Shannon M., Noone P., Gascoigne E., Fox J., Boesen E. Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet. 1982 Apr 10;1(8276):826–829. doi: 10.1016/s0140-6736(82)91874-8. [DOI] [PubMed] [Google Scholar]
  9. Jordan W. M., Bodey G. P., Rodriguez V., Ketchel S. J., Henney J. Miconazole therapy for treatment of fungal infections in cancer patients. Antimicrob Agents Chemother. 1979 Dec;16(6):792–797. doi: 10.1128/aac.16.6.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Koeffler H. P., Golde D. W. Amphotericin inhibition of hematopoiesis in vitro. Am J Hematol. 1977;3:57–62. doi: 10.1002/ajh.2830030107. [DOI] [PubMed] [Google Scholar]
  11. Krick J. A., Remington J. S. Opportunistic invasive fungal infections in patients with leukaemia lymphoma. Clin Haematol. 1976 Jun;5(2):249–310. [PubMed] [Google Scholar]
  12. MacGregor R. R., Bennett J. E., Erslev A. J. Erythropoietin concentration in amphotericin B-induced anemia. Antimicrob Agents Chemother. 1978 Aug;14(2):270–273. doi: 10.1128/aac.14.2.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McGuffin R. W., Shiota F. M., Meyers J. D. Lack of toxicity of acyclovir to granulocyte progenitor cells in vitro. Antimicrob Agents Chemother. 1980 Sep;18(3):471–473. doi: 10.1128/aac.18.3.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Medoff G., Kobayashi G. S. Strategies in the treatment of systemic fungal infections. N Engl J Med. 1980 Jan 17;302(3):145–155. doi: 10.1056/NEJM198001173020304. [DOI] [PubMed] [Google Scholar]
  15. Pizzo P. A., Robichaud K. J., Gill F. A., Witebsky F. G. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med. 1982 Jan;72(1):101–111. doi: 10.1016/0002-9343(82)90594-0. [DOI] [PubMed] [Google Scholar]
  16. Singer J. W., Fialkow P. J., Steinmann L., Najfeld V., Stein S. J., Robinson W. A. Chronic myelocytic leukemia (CML): failure to detect residual normal committed stem cells in vitro. Blood. 1979 Feb;53(2):264–268. [PubMed] [Google Scholar]
  17. Stevens D. A., Levine H. B., Deresinski S. C. Miconazole in coccidiodomycosis. II. Therapeutic and pharmacologic studies in man. Am J Med. 1976 Feb;60(2):191–202. doi: 10.1016/0002-9343(76)90428-9. [DOI] [PubMed] [Google Scholar]
  18. Winston D. J., Gale R. P., Meyer D. V., Young L. S. Infectious complications of human bone marrow transplantation. Medicine (Baltimore) 1979 Jan;58(1):1–31. doi: 10.1097/00005792-197901000-00001. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES